-+ 0.00%
-+ 0.00%
-+ 0.00%

Moleculin Biotech Q1 EPS $(3.54) Misses $(1.57) Estimate

Benzinga·05/15/2026 13:20:01
Listen to the news
Moleculin Biotech (NASDAQ:MBRX) reported quarterly losses of $(3.54) per share which missed the analyst consensus estimate of $(1.57) by 125.48 percent. This is a 77.59 percent increase over losses of $(15.80) per share from the same period last year.